Search

Search Results

• 

  Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature

  M. Varenna, F. Bertoldo, M. Di Monaco, A. Giusti, G. Martini, M. Rossini, On behalf of SIOMMMS, Endorsed by SIR

  143-166

  31-10-2013

  https://doi.org/10.4081/reumatismo.2013.143

  7034

  PDF: 2519

• Side effects of anti-TNFa therapy in juvenile idiopathic arthritis

  Irene Pontikaki, Valeria Gerloni, Maurizio Gattinara, Alfredomaria Lurati, Alessandra Salmaso, Gabriele De Marco, Barbara Teruzzi, Elisabetta Valcamonica, Flavio Fantini

  31-38

  https://doi.org/10.4081/reumatismo.2006.31

  1777

  PDF: 2516

• CONVENTIONAL THERAPIES FOR PSORIASIS

  A. Rebora

  77-80

  https://doi.org/10.4081/reumatismo.2007.1s.77

  869

  PDF: 857
• 

  Update on treatment of polymyalgia rheumatica

  D. Camellino, C. Dejaco

  59-66

  27-03-2018

  https://doi.org/10.4081/reumatismo.2018.1062

  5789

  PDF: 3356
• 

  Fibromyalgia and sexual problems

  L. Bazzichi, C. Giacomelli, A. Rossi, F. Sernissi, P. Scarpellini, A. Consensi, S. Bombardieri

  261-267

  28-09-2012

  https://doi.org/10.4081/reumatismo.2012.261

  2748

  PDF: 1989
• 

  Perspectives and unmet needs in polymyalgia rheumatica. Providing the fundamental framework for the development of new treatment regimes in polymyalgia rheumatica

  B.D. Nielsen, B. Dasgupta

  1-9

  27-03-2018

  https://doi.org/10.4081/reumatismo.2018.1070

  2126

  PDF: 1555
• 

  Real-world experiences of folic acid supplementation (5 versus 30 mg/week) with methotrexate in rheumatoid arthritis patients: a comparison study

  K.T. Koh, C.L. Teh, C.K. Cheah, G.R. Ling, M.C. Yong, H.C. Hong, S.C. Gun

  90-96

  09-09-2016

  https://doi.org/10.4081/reumatismo.2016.872

  2435

  PDF: 1370

• The treatment of diffuse cutaneous systemic sclerosis with autologous hemopoietic stem cells transplantation (HSCT): our experience on 2 cases

  I. Miniati, R. Saccardi, F. Pagliai, S. Guiducci, A. Bosi, S. Guidi, S. Urbani, A. Tyndall, M. Matucci Cerinic

  277-282

  https://doi.org/10.4081/reumatismo.2005.277

  959

  PDF: 1493

• Sodium-gold thyosolphatum therapy: an open, viewed, multicenter trial in rheumatoid arthritis patients followed for two years

  M.L. Ciompi, C. Amoresano, P. Balzarini, L.M. Bazzichi, M. Broggini, L. Buratti, F. Calcagnile, A. Ciocci, S. Ferri, C. Fichera, M. Fumagalli, M. Muratore, F. Nitti, G. Peruz, G. Romagnoni

  251-256

  https://doi.org/10.4081/reumatismo.2002.251

  873

  PDF: 1304

• Safety of anti-TNFa biological drugs

  F. Trotta, G. Valentini

  34-39

  https://doi.org/10.4081/reumatismo.2005.4s.34

  1128

  PDF: 1120

• Safety profile of 185 ultrasound-guided intra-articular injections for treatment of rheumatic diseases of the hip

  A. Migliore, S. Tormenta, L.S. Martin Martin, C. Valente, U. Massafra, A. Latini, A. Alimonti

  104-109

  https://doi.org/10.4081/reumatismo.2004.104

  1213

  PDF: 1010

• The impact of nicotine smoking on spondyloarthritis and rheumatoid arthritis

  G. El Hasbani, J. E Nassar, A.M. Elsayed Ali, I. Uthman, A. Jawad

  24-06-2024

  https://doi.org/10.4081/reumatismo.2024.1572

  3903

  PDF: 1356

• Thalidomide in treatment of connective diseases and vasculities

  N. Maruotti, F.P. Cantatore, D. Ribatti

  187-190

  https://doi.org/10.4081/reumatismo.2006.187

  1394

  PDF: 1123

• Kidney involvement in rheumatoid arthritis

  A. Icardi, P. Araghi, M. Ciabattoni, U. Romano, P. Lazzarini, G. Bianchi

  76-85

  https://doi.org/10.4081/reumatismo.2003.76

  5500

  PDF: 7583

• 18 month observational study on efficacy of intraarticular hyaluronic acid (Hylan G-F 20) injections under ultrasound guidance in hip osteoarthritis

  Alberto Migliore, Sandro Tormenta, Umberto Massafra, Luis Severino Martin Martin, Emilia Carloni, Cristiano Padalino, Andrea Alimonti, Mauro Granata

  39-49

  https://doi.org/10.4081/reumatismo.2006.39

  1571

  PDF: 1087
• 

  Erythema nodosum after COVID-19 vaccine

  B. Maranini, G. Ciancio, M. Corazza, F. Ruffilli, G. Galoppini, M. Govoni

  03-05-2022

  https://doi.org/10.4081/reumatismo.2022.1475

  2602

  PDF: 994

• Safety of rituximab in rheumatoid arthritis

  M. Covelli, P. Sarzi-Puttini, F. Atzeni, P. Macchioni

  101-106

  https://doi.org/10.4081/reumatismo.2010.101

  1649

  PDF: 991

• Long term functional outcome of idiopathic inflammatory myopathies

  R. Neri, M. Mosca, T. Grazzini, A. Tavoni, G. Pasero, S. Bombardieri

  40-45

  https://doi.org/10.4081/reumatismo.2001.40

  1044

  PDF: 945

• Chronic inflammation and endothelial dysfunction: analysis of a cohort of patients with SLE and UCTD

  C. Tani, M. Mosca, A. d'Ascanio, D. Versari, A. Virdis, L. Ghiadoni, S. Taddei, A. Salvetti, S. Bombardieri

  212-218

  https://doi.org/10.4081/reumatismo.2006.212

  1757

  PDF: 1313

• Idiopathic hypereosinophilic syndrome associated with rheumatoid arthritis A case report

  D. Bonanno, R. Fedele, P. Minciullo, P. Quattrocchi, B. Ferlazzo

  181-183

  https://doi.org/10.4081/reumatismo.2003.181

  1919

• Biologic therapy with anti-TNFa in rheumathoid atrhritis

  G. Ferraccioli

  17-21

  https://doi.org/10.4081/reumatismo.2005.4s.17

  743

  PDF: 673
• 

  Disseminated cutaneous herpes simplex infection after COVID-19 vaccination in a rheumatoid arthritis patient: a case report and review

  D. Mohamadzadeh, S. Assar, M. Pournazari, P. Soufivand, S. Danaei

  13-09-2022

  https://doi.org/10.4081/reumatismo.2022.1489

  1647

  PDF: 867

• Blocking TNF in vitro with infliximab determines the inhibition of expansion and interferon gamma production of Vγ9/Vδ2 T lymphocytes from patients with active rheumatoid arthritis. A role in the susceptibility to tuberculosis?

  A.R. Giardina, A. Accardo-Palumbo, F. Ciccia, A. Ferrante, A. Principato, R. Impastato, G. Triolo

  21-26

  https://doi.org/10.4081/reumatismo.2009.21

  1406

  PDF: 1086
• 

  Chronic pain: the burden of disease and treatment innovations

  S. Monti, R. Caporali

  35-44

  23-10-2015

  https://doi.org/10.4081/reumatismo.2015.840

  3900

  PDF: 2631

• Adherence to treatment of osteoporosis: an open question

  M. Varenna, L. Sinigaglia

  4-9

  https://doi.org/10.4081/reumatismo.2009.4

  1267

  PDF: 924
• 

  Herpes zoster infection following mRNA COVID-19 vaccine in a patient with ankylosing spondylitis

  B. Maranini, G. Ciancio, R. Cultrera, M. Govoni

  22-11-2021

  https://doi.org/10.4081/reumatismo.2021.1445

  7278

  PDF: 955
• 

  Inflammatory back pain as an unusual manifestation of Takayasu arteritis: a case report

  Faiq Gorial, Nabaa Awadh, Ali Al-Shakarchi, Ghaith Al-Gburi

  30-10-2024

  https://doi.org/10.4081/reumatismo.2024.1678

  1591

  PDF: 256

• The treatment of recurrent uveitis with TNFα inhibitors

  P.C.F. Falappone, F. Iannone, C. Scioscia, V. Grattagliano, M. Covelli, G. Lapadula

  185-189

  https://doi.org/10.4081/reumatismo.2004.185

  1726

  PDF: 2352

• The treatment of skin ulcers in systemic sclerosis: use of granulocyte-colony stimulating factor (G-CSF) in 26 patients

  Dilia Giuggioli, Rocco Magistro, Michele Colaci, Umberto Franciosi, Andrea Caruso, Clodoveo Ferri

  26-30

  https://doi.org/10.4081/reumatismo.2006.26

  959

  PDF: 1106

• Chronic osteomyelitis: a new therapeutical idea

  G. Carlino, P. Trande, M. Muratore, E. De Micheli, G. Santacesaria

  309-311

  https://doi.org/10.4081/reumatismo.2001.309

  699

  PDF: 830
• 

  Sex and gender differences in comorbidities in spondyloarthritis: a focus on psoriatic arthritis

  F. Atzeni, C. Siragusano, A. Tropea, A. Alciati

  11-09-2024

  https://doi.org/10.4081/reumatismo.2024.1769

  1340

  PDF: 506

• How much does an antiinflammatory treatment cost?

  D. Gatti, O. Viapiana, G. Colombo, S. Adami

  248-252

  https://doi.org/10.4081/reumatismo.2010.248

  1235

  PDF: 647

• Efficacy and safety of Amtolmetin Guacyl in the symptomatic treatment of the osteoarthritis

  G. Biasi, L. Moltoni, C. Acciai, S. Di Martino, R. Marcolongo

  145-150

  https://doi.org/10.4081/reumatismo.2001.145

  987

  PDF: 701

• Therapy of rheumatic polymyalgia: the pathophysiologic management

  M. Cutolo, M. Olivieri, M.E. Secchi, M.A. Cimino

  271-279

  https://doi.org/10.4081/reumatismo.2007.271

  1464

  PDF: 2083

• Approved indications and other possible utilizations of anti-TNFa biologic drugs

  W. Grassi, C. Montecucco

  30-33

  https://doi.org/10.4081/reumatismo.2005.4s.30

  1126

  PDF: 872